Showing 141 - 160 results of 248 for search '"macular degeneration"', query time: 0.07s Refine Results
  1. 141

    Selecting drug formulation for the treatment and prevention of retinal disorders by O.V. Filippova

    Published 2019-11-01
    “…Among them, age-related macular degeneration (AMD) leads to significant visual impairment and irreversible blindness in millions of patients worldwide. …”
    Get full text
    Article
  2. 142

    New possibilities of using methylaethylpiridinolum in ophthalmological practice by E.A. Egorov, A.A. Gvetadze

    Published 2019-01-01
    “…<br> <br> <b>Key words:</b> oxidative stress, reactive oxygen species, methylaethylpiridinolum, antioxidant, sodium hyaluronate, retinoprotection, diabetic retinopathy, glaucoma, age-related macular degeneration.<br> <b>For citation:</b> Egorov E.A., Gvetadze A.A. …”
    Get full text
    Article
  3. 143

    The effect of intravitreal injection of anti-VEGF drugs on the ophthalmotonus values in patients with classic and occult choroidal neovascularization by A.V. Kuroyedov, Zakharova M.A., O.V. Gapon’ko, V.V. Gorodnichiy

    Published 2018-07-01
    “…<br> <b>Patients and Methods:</b> 34 patients (40 eyes) with age-related macular degeneration were divided into 2 groups. Group 1 —&nbsp;the patients (19 eyes) with classic CNV, group 2 — the patients (21 eyes) with occult CNV. …”
    Get full text
    Article
  4. 144

    Recent Advances and the Mechanism of Astaxanthin in Ophthalmological Diseases by Ming Yang, Yanling Wang

    Published 2022-01-01
    “…This article reviews the function and the potential mechanism of AST in dry eye syndrome, keratitis, cataract, diabetic retinopathy, age-related macular degeneration, high intraocular pressure, and other ocular diseases. …”
    Get full text
    Article
  5. 145

    High-Resolution Optical Coherence Tomography Retinal Imaging: A Case Series Illustrating Potential and Limitations by Olena Puzyeyeva, Wai Ching Lam, John G. Flanagan, Michael H. Brent, Robert G. Devenyi, Mark S. Mandelcorn, Tien Wong, Christopher Hudson

    Published 2011-01-01
    “…The series comprised four selected cases (one case each) of age-related macular degeneration (ARMD), diabetic retinopathy (DR), central retinal artery occlusion (CRAO), and branch retinal vein occlusion (BRVO). …”
    Get full text
    Article
  6. 146

    The effects of antioxidants, angioprotective agents, and vitamins on retina in complex retinal diseases by I.V. Vorobyeva, A.A. Dement’eva, A. Dgebuadze

    Published 2020-06-01
    “…</i> </p> <p> <i><b>Keywords</b>: diabetic retinopathy, age-related macular degeneration, lutein, zeaxanthin, troxerutin, vitamins B, vitamin C, vitamin E, folic acid, zinc.…”
    Get full text
    Article
  7. 147

    Nuances of preoperative care before cataract extraction. What do we overlook when performing biometry, calculating IOL power, and examining the eye? by A.B. Movsisyan, A.E. Egorov

    Published 2021-09-01
    “…Supplements containing macular pigments prevent macular degeneration and protect the macular zone.</i> </p> <p> <i><b>Keywords</b>: cataract, refraction, cataract surgery, biometry, IOL power calculation, IOL power calculation formulas, retina, age-related macular degeneration.…”
    Get full text
    Article
  8. 148

    Inhibiting the alternative pathway of complement by reducing systemic complement factor B: Randomized, double-blind, placebo-controlled phase 1 studies with Sefaxersen by Michael L. McCaleb, Steven G. Hughes, Tamar R. Grossman, Ashley Frazer-Abel, Bill Jung, Lixuan Yin, Scott P. Henry, Brett P. Monia, Eugene Schneider, Richard Geary, Gary T. Brice

    Published 2025-03-01
    “…These clinical results support the ongoing Phase 2 development for geographic atrophy secondary to age-related macular degeneration and Ph 2/3 development for IgA nephropathy.…”
    Get full text
    Article
  9. 149

    Clinical trials on carotenoids and vitamin mineral supplements in ophthalmology by A.A. Gvetadze, M.G. Rabadanova

    Published 2019-04-01
    “…The authors discuss etiology and pathogenesis of age-related macular degeneration (AMD) as well as the role of oxidative stress. …”
    Get full text
    Article
  10. 150

    Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease by Scott D. Schoenberger, Stephen J. Kim

    Published 2013-01-01
    “…For example, therapeutic effects on diabetic retinopathy and age-related macular degeneration may now be achievable. We provide an updated review on the scientific rationale and clinical use of NSAIDs for retinal disease.…”
    Get full text
    Article
  11. 151

    Lutein and inflammation: a comprehensive review of its mechanisms of action by Paradentavida Prathyusha, Geetha Viswanathan, Anjilikal Tomy Tomcy, Ponnamparambil P. Binitha, Smitha V. Bava, Edakkadath R. Sindhu

    Published 2025-01-01
    “…Additionally, it discusses lutein’s beneficial impact on macular degeneration and eye diseases, showcasing its potential as a natural, plant-based therapeutic agent.…”
    Get full text
    Article
  12. 152

    Anti-VEGF Treatment Strategies for Wet AMD by Jaclyn L. Kovach, Stephen G. Schwartz, Harry W. Flynn, Ingrid U. Scott

    Published 2012-01-01
    “…Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. …”
    Get full text
    Article
  13. 153

    Pharmacotherapy for AMD: state-of-the-art by I.A. Koroleva, A.A. Gvetadze, T.B. Romanova

    Published 2019-07-01
    “…<p> <i>The article discusses the evolution of the treatment for a socially important disease, age-related macular degeneration (AMD). Data on earlier and recent treatment for “wet” AMD as well as promising trends in the development of novel medications are addressed.…”
    Get full text
    Article
  14. 154

    Future of artificial intelligence for the diagnosis and treatment of retinal diseases by E.A. Katalevskaya, D.Yu. Katalevskiy, M.I. Tyurikov, I.A. Velieva, A.V. Bol’shunov

    Published 2022-02-01
    “…., diabetic retinopathy, diabetic macular edema, age-related macular degeneration) to provide a personalized management strategy. …”
    Get full text
    Article
  15. 155

    Retinal Pigment Epithelium Transplantation: Past, Present, and Future by Ayyad Zartasht Khan, Tor Paaske Utheim, Jon Roger Eidet

    Published 2022-11-01
    “…Damaged RPE is associated with diseases such as age-related macular degeneration, Stargardt's macular dystrophy, and retinitis pigmentosa. …”
    Get full text
    Article
  16. 156

    Management of Uveitis-Related Choroidal Neovascularization: From the Pathogenesis to the Therapy by Enzo D’Ambrosio, Paolo Tortorella, Ludovico Iannetti

    Published 2014-01-01
    “…Its pathogenesis is supposed to be similar to the wet age related macular degeneration: hypoxia, release of vascular endothelial growth factor, stromal cell derived factor 1-alpha, and other mediators seem to be involved in the uveitis-related choroidal neovascularization. …”
    Get full text
    Article
  17. 157

    Examining the Choroid in Ocular Inflammation: A Focus on Enhanced Depth Imaging by Abeir Baltmr, Sue Lightman, Oren Tomkins-Netzer

    Published 2014-01-01
    “…The choroid is the vascular layer that supplies the outer retina and is involved in the pathogenesis of several ocular conditions including choroidal tumors, age related macular degeneration, central serous chorioretinopathy, diabetic retinopathy, and uveitis. …”
    Get full text
    Article
  18. 158

    Alzheimer’s Disease as a Result of Stimulus Reduction in a GABA-A-Deficient Brain: A Neurocomputational Model by Mariana Antonia Aguiar-Furucho, Francisco Javier Ropero Peláez

    Published 2020-01-01
    “…Several research studies point to the fact that sensory and cognitive reductions like cataracts, deafness, macular degeneration, or even lack of activity after job retirement, precede the onset of Alzheimer’s disease. …”
    Get full text
    Article
  19. 159

    The endocannabinoid system and ophthalmic pathologies: a review of molecular mechanisms and its implications for clinical practice by Tomasz Charytoniuk, Stanisław Półjanowski, Mateusz Michalak, Karolina Kaźmierczak, Bartłomiej Kałużny

    Published 2025-02-01
    “…Furthermore, various research indicated the involvement of ECS in the molecular basis of various pathologies, mostly glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD). Therefore, the researchers believe that this biological system, its receptors, pathways, and ligands might be considered as an auxiliary compound to reduce the number of patients suffering from ophthalmic diseases. …”
    Get full text
    Article
  20. 160

    Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering by Karim Ben M’Barek, Christelle Monville

    Published 2019-01-01
    “…Retinal degeneration is an irreversible phenomenon caused by various disease conditions including age-related macular degeneration (AMD) and retinitis pigmentosa (RP). …”
    Get full text
    Article